Press Releases
Food Processors Get a 360-Degree View of Line Performance with Mettler-Toledo’s ProdX 2.0
To supportglobal food manufacturers in meeting the documentation and active managerial control requirements of the Food Safety Modernisation Act (FSMA). When...
Drug Research
LDC and SOTIO Enter License and Collaboration Agreement for First-in-class Cancer Metabolism Program
The Lead Discovery Center GmbH (LDC), Max Planck Innovation GmbH (MI) and SOTIO a.s. have signed a collaboration and license agreement providing SOTIO with...
News
Neurocrine Announces FDA Approval of INGREZZA TM Capsules
Neurocrine Biosciences, Inc. announced that the U.S. FDA has approved INGREZZATM (valbenazine) capsules for the treatment of adults with tardive dyskinesia (TD). ...
Press Releases
DiscoverX Partners with B’SYS GmbH to Expand SAFETYscan In Vitro Pharmacological Profiling Services
DiscoverX Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development announced their partnership with B’SYS GmbH to expand DiscoverX’s...
Press Releases
Eyevensys receives French regulatory approval to advance EyeCET platform
Eyevensys, a private biotechnology company developing its proprietary EyeCET platform, the first non-viral gene expression technology that enables the safe, local, sustained production of...
Clinical Trials
Inovio Ebola Vaccine Demonstrates Robust Immune Responses with Favorable Safety Profile in Expanded Clinical Trial
Inovio Pharmaceuticals, Inc. announced preliminary results from the expanded stage of its phase I study, EBOV-001. The expanded study examined different regimens of its...
Clinical Trials
Cytori Receives FDA Approval for Burn Clinical Trial Related to BARDA Contract
Cytori Therapeutics, Inc. announced that the U.S. FDA has approved an IDE for a pilot clinical trial to evaluate Cytori Cell Therapy™ in patients...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read